Latest

First Opinion Sanjula Jain

Deferral of primary care signals a troubled future for Americans’ health

Health Andrew Joseph

Limits of ‘Fauci effect’: infectious disease applicants plummet, and hospitals are scrambling

Health Elaine Chen

Eli Lilly tightens access to diabetes drug, frustrating some people with obesity

Health Tech Casey Ross

A new coalition aims to close AI’s credibility gap in medicine with testing and oversight

Pharmalot Ed Silverman

Zantac lawsuits are tossed out as judge lambasts lack of evidence showing links to cancer

Pharmalot Ed Silverman

The prices of 7 drugs were hiked without proof of new benefits, costing the U.S. $805 million in 2021

Health Tech Mario Aguilar

Apple scores victory in dispute over heart monitoring technologies in Apple Watch

Pharmalot Ed Silverman

France’s drug regulator is under investigation for its handling of a thyroid drug

Biotech Matthew Herper and Allison DeAngelis

‘This is not a cure’: Consensus begins to emerge on new Alzheimer’s drug

Health Matthew Herper

STATUS List Spotlight: A Conversation with Otis Brawley

Pharmalot Ed Silverman

U.S. delays backing for patent waivers on Covid-19 therapies and diagnostics

First Opinion Earl Smith

Victims of domestic abuse should get the same top-notch concussion care as athletes

Biotech Adam Feuerstein

Gossamer drug for lung hypertension achieves study goal but with subpar treatment effect

Pharmalot Ed Silverman

Pharmalittle: FDA fast tracks OTC version of Narcan; Express Scripts to keep Humira on its formulary but add biosimilars

Biotech Matthew Herper

Karuna Therapeutics replaces its CEO, suggesting takeover unlikely soon

Health Lev Facher

Congress has its sights set too low on addiction, advocates charge

First Opinion Sallie Permar and Robert J. Vinci

Pediatricians and parents on the brink: This is their March 2020

Health Tech Mario Aguilar

‘Who is the real pioneer?’: Apple and AliveCor go head-to-head over crucial heart monitoring tech for smartwatches

Business Tara Bannow and Olivia Goldhill

Psychedelic therapy is moving to the next frontier: workplace perk

Biotech Adam Feuerstein

Mirati’s KRAS-blocking lung cancer drug clears safety hurdle in combination study

In the Lab Megan Molteni

New concerns about a paper co-authored by Stanford president prompt journal to take a ‘closer look’

Pharmalot Ed Silverman

A year after petition, NIH will finally review request to lower cancer drug’s cost by sidestepping patents

First Opinion Scott Gottlieb and Mark B. McClellan

Congress needs to update FDA’s ability to regulate diagnostic tests, cosmetics

Pharmalot Ed Silverman

Pharmalittle: J&J drops out of bidding for Horizon; FDA takes a harder line on fast-track approvals

First Opinion Greg Yap and Derek Xiao

Carefully crafted digital approaches can improve youths’ mental health care

Health Tech Casey Ross

An AI model to predict kidney damage, trained on data from veterans, works less well in women

Health Tech Usha Lee McFarling

Before making unbiased pulse oximeters, researchers need a better way to measure skin tone

Insurance Bob Herman

The health insurer will see you now: How UnitedHealth is keeping more profits, as your doctor

Exclusive Katie Palmer

Thirty Madison, looking to stand out in a crowded telehealth market, quietly plans expansion into sleep care